Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001181431-05-055585
Filing Date
2005-10-05
Accepted
2005-10-05 15:37:41
Documents
1
Period of Report
2005-10-03

Document Format Files

Seq Description Document Type Size
1 FORM 4/A - RESTRICTED STOCK GRANT rrd93908.html 4/A  
1 FORM 4/A - RESTRICTED STOCK GRANT rrd93908.xml 4/A 3518
  Complete submission text file 0001181431-05-055585.txt   5220
Mailing Address
Business Address 321 ARSENAL STREET WATERTOWN MA 02472 6176737800
OXIGENE INC (Issuer) CIK: 0000908259 (see all company filings)

IRS No.: 133679168 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 2 SUTTON PLACE SOUTH, 19A NEW YORK NY 10022
Business Address 2124048910
Zecher Richard (Reporting) CIK: 0001303511 (see all company filings)

Type: 4/A | Act: 34 | File No.: 000-21990 | Film No.: 051124820